Form 4: Saba Capital Boosts Stake in Gabelli Healthcare Trust

Saba Capital Management, a 10% owner and director, increased its beneficial ownership in Gabelli Healthcare & WellnessRx Trust through recent common stock purchases.

Summary

• Saba Capital Management, L.P., identified as a 10% owner and director of Gabelli Healthcare & WellnessRx Trust (GRX), reported two purchases of common stock.
• On October 16, 2025, Saba Capital acquired 3,520 shares of common stock at a price of $9.18 per share.
• Following this transaction, Saba Capital's indirect beneficial ownership stood at 2,054,555 shares.
• On October 17, 2025, an additional 5,816 shares of common stock were purchased at $9.20 per share.
• After the second transaction, Saba Capital's total indirect beneficial ownership increased to 2,060,371 shares of common stock.

Sentiment

Score: 8

Explanation: The sentiment is positive due to significant insider buying by a 10% owner and director, indicating strong confidence in the company's outlook.

Positives

• A significant 10% owner and director, Saba Capital Management, L.P., increased its stake in the company, signaling confidence in the issuer's prospects.
• The purchases were made at market prices of $9.18 and $9.20, indicating a willingness to invest at current valuations.

Risks

• The filing itself does not detail specific risks, but general investment risks associated with the Gabelli Healthcare & WellnessRx Trust and the healthcare sector remain.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance from the issuer or reporting person beyond the transaction details.

Industry Context

The Gabelli Healthcare & WellnessRx Trust is a closed-end fund focused on the healthcare and wellness sectors. Insider buying by a significant shareholder like Saba Capital Management could be interpreted as a positive signal for the fund's future performance within its specialized industry, especially given the ongoing dynamics and investment opportunities in healthcare.

Comparison to Industry Standards

• This filing reports an insider transaction, which is a standard disclosure requirement for public companies and their affiliates under Section 16(a) of the Securities Exchange Act of 1934. It does not provide performance metrics for direct comparison to industry benchmarks or competitors.
• Insider buying by a 10% owner and director, such as Saba Capital Management, is generally viewed as a strong indicator of confidence, aligning with similar signals observed when large institutional investors or board members increase their holdings in other closed-end funds or public companies.

Stakeholder Impact

• Shareholders may view the increased stake by a major investor and director as a positive sign, potentially boosting investor confidence.
• The transactions reflect the reporting person's investment strategy and belief in the value of the Gabelli Healthcare & WellnessRx Trust.

Next Steps

• Saba Capital Management, L.P. will continue to report any further changes in its beneficial ownership of Gabelli Healthcare & WellnessRx Trust securities as required by SEC regulations.

Key Dates

Recommendation

The significant insider buying by Saba Capital Management, L.P., a 10% owner and director, suggests strong conviction in the Gabelli Healthcare & WellnessRx Trust's valuation and future performance. Such actions by informed insiders often precede positive developments or reflect an undervalued asset, making it a compelling signal for potential investors.

Keywords

Gabelli Healthcare & WellnessRx Trust, GRX, Saba Capital Management, Insider Buying, Common Stock, Investment, Healthcare Sector, Closed-End Fund